MagnesioBoi 48.62 mg tablets
Spain
Table of Contents
Package leaflet: Information for the user
Introduction
Package leaflet: information for the user
Magnesioboi 48.62 mg tablets
Magnesium
Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.
Follow exactly the instructions for administration provided in this leaflet or those indicated by your doctor or pharmacist.
-
Keep this leaflet, as you may need to read it again.
-
If you need advice or more information, consult your pharmacist.
- If you experience any adverse effects, consult your doctor or pharmacist, even if these are effects not listed in this leaflet. See section 4.
-
You should consult a doctor if your condition worsens or if you do not improve after 7 days.
Contents of this leaflet
- What Magnesioboi is and what it is used for
- What you need to know before taking Magnesioboi
- How to take Magnesioboi
- Possible side effects
- How to store Magnesioboi
- Contents of the pack and other information
1. What Magnesioboi is and what it is used for
This medicine contains magnesium lactate. It belongs to a group of medicines called "mineral supplements".
It is used to prevent magnesium deficiency states due to diets low in vegetables, whole grains, and legumes, which may manifest as weakness and muscle cramps in adults and children over 12 years of age.
You should consult a doctor if your condition worsens or does not improve after 7 days.
2. What you need to know before starting to take Magnesioboi
Do not take Magnesioboi:
- if you are allergic to magnesium lactate or to any of the other ingredients of this medicine (listed in section 6),
- if you have severe renal insufficiency (markedly reduced kidney function),
- if you currently have or have had heart diseases such as angina pectoris or myocardial infarction,
- if you currently have or have had diabetic coma (loss of consciousness due to excessively high or low blood sugar levels),
- if you have been diagnosed with myasthenia gravis (an autoimmune neuromuscular disease),
- if you suffer from chronic diarrhea or have been diagnosed with inflammatory bowel disease (ulcerative colitis),
- if you have undergone intestinal surgery (ileostomy),
- if you have symptoms of appendicitis: abdominal pain (pain around the navel) that increases in intensity and shifts to the lower right side of the abdomen as the condition progresses. This pain may be accompanied by loss of appetite, nausea, vomiting, and low-grade fever.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Magnesioboi.
- Prolonged use of this medicine may cause hypermagnesemia (high levels of magnesium in the blood), characterized by nausea, vomiting, respiratory depression (weak breathing), and depression of the central nervous system (symptoms may range from drowsiness to coma), hyperreflexia (exaggerated reflexes), muscle weakness, and certain cardiovascular effects such as low blood pressure, decreased heart rate, and cardiac arrest.
- Taking this medicine on an empty stomach may cause diarrhea.
- Patients with kidney disease should consult their doctor before taking this medicine.
Children and adolescents
Do not administer to children under 12 years of age unless otherwise directed by a physician.
Elderly patients
In patients over 65 years of age who have reduced kidney function, the dose and frequency of administration of magnesium salts should be adjusted by the physician according to the degree of renal impairment.
Use of Magnesioboi with other medicines
Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.
This medicine reduces the absorption of:
- Antibiotics such as tetracyclines (doxycycline, minocycline, oxytetracycline, tetracycline) and quinolones (ciprofloxacin, levofloxacin, norfloxacin, ofloxacin).
- Bisphosphonates (medicines used in the treatment of osteoporosis).
Magnesioboi and these medicines should be taken at least 2 hours apart to avoid unwanted interactions.
Taking Magnesioboi with food and drink
Excessive and prolonged consumption of products containing magnesium and calcium may lead to elevated calcium levels in the blood. In such cases, calcium intake and consumption of calcium-rich foods, such as dairy products, should be monitored.
This medicine should be taken after meals.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.
It is recommended to meet magnesium requirements through a diet rich in vegetables, whole grains, and legumes to prevent consequences of magnesium deficiency during pregnancy.
No problems have been reported in breastfed infants whose mothers take magnesium at recommended doses.
Driving and using machines
The effect of magnesium on the ability to drive and operate machinery is negligible or none.
Magnesioboi contains lactose
This medicine contains lactose. If your doctor has informed you that you have an intolerance to certain sugars, consult with him before taking this medicine.
3. How to take Magnesioboi
Follow exactly the instructions for use provided in this leaflet or those given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist.
The recommended dose for adults and children over 12 years of age is 1 to 2 tablets (48.62 mg to 97.24 mg of magnesium) after each of the three daily meals (146 mg to 292 mg of magnesium per day). The tablets should be taken with a sufficient amount of liquid.
The maximum recommended dose must not be exceeded (6 tablets per day).
Elderly patients, children under 12 years of age, and patients with kidney disease should consult their doctor.
This medicine is administered orally.
If symptoms worsen or do not improve within 7 days of treatment, consult your doctor.
If you take more Magnesioboi than you should
If you have taken more medicine than you should, consult your doctor or pharmacist immediately.
In cases of intoxication due to ingestion of high doses, or in patients with renal insufficiency and reduced urine output, an increase in blood magnesium levels may occur. In such cases, the following symptoms may appear: nausea, vomiting, drowsiness, double vision, dizziness, speech disturbances, difficulty swallowing, muscle weakness, skin flushing, decreased blood pressure, cardiac rhythm disturbances, and cardiac arrest.
In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately or call the Toxicology Information Service (Telephone 91.562.04.20), stating the medicine taken and the amount ingested.
If you forget to take Magnesioboi
Do not take a double dose to make up for a missed dose. Take the dose as soon as you remember, then continue your treatment as before.
If you have any further questions about the use of this medicine, consult your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.
The following adverse effects have been reported during the period of use of this medicine, although their frequency could not be established accurately. The most frequently occurring ones are gastrointestinal disturbances, such as diarrhea and vomiting, and, less frequently, increased magnesium levels in blood, which may be associated with the following symptoms: somnolence, double vision, dizziness, muscle weakness, and decreased blood pressure.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You may also report them directly through the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Storage of Magnesioboi
Keep this medicine out of the sight and reach of children.
No special storage conditions are required.
Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date is the last day of the month indicated.
Medicines must not be disposed of via wastewater or household waste. Dispose of empty containers and unused medicines at the SIGRE Point in your pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medicines you no longer need. This will help protect the environment.
6. Contents of the pack and other information
Composition of Magnesioboi
The active substance is magnesium lactate. Each tablet contains 48.62 mg of magnesium, provided by 404.85 mg of magnesium lactate.
The other components (excipients) are: monohydrate lactose, macrogol 6000, sodium croscarmellose, magnesium stearate and talc.
Appearance of the product and contents of the pack
Magnesioboi is presented as round, biconvex, bone-white tablets. Each pack contains 50 tablets.
Marketing Authorization Holder
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) – Spain
Manufacturer
P&G Health Austria GmbH & Co. OG
Hösslgasse 20
9800 Spittal an der Drau
Austria
or
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) – Spain
Date of the most recent revision of this leaflet: January 2011
Detailed information on this medicine is available on the website of the Spanish Agency of Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).